University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Recent advances in incretin-based therapies.

Russell-Jones, D and Gough, S (2012) Recent advances in incretin-based therapies. Clin Endocrinol (Oxf), 77 (4). pp. 489-499.

Full text not available from this repository.

Abstract

The global burden of type 2 diabetes is growing. Traditional therapies are suboptimal and there is a clear unmet need for treatments that offer effective glucose control while addressing the comorbid factors associated with diabetes, such as obesity and risk of cardiovascular disease, without the fear of hypoglycaemia. Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors offer a novel way of reducing hyperglycaemia by targeting the incretin system. This review provides an overview of the development of incretin-based therapies and explains their differing modes of action compared with traditional interventions. A comparison of the clinical profiles of current glucagon-like peptide-1 receptor agonists [liraglutide and exenatide (twice-daily and once-weekly)] and dipeptidyl peptidase-4 inhibitors (sitagliptin, saxagliptin, vildagliptin and linagliptin) is performed alongside a discussion of the placement of incretin-based therapies in treatment guidelines. Further improvements in this class are expected, and we will examine some of the novel glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors currently under development.

Item Type: Article
Authors :
NameEmailORCID
Russell-Jones, Ddavidrussell-jones@nhs.netUNSPECIFIED
Gough, SUNSPECIFIEDUNSPECIFIED
Date : October 2012
Identification Number : https://doi.org/10.1111/j.1365-2265.2012.04483.x
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:44
Last Modified : 17 May 2017 09:44
URI: http://epubs.surrey.ac.uk/id/eprint/824936

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800